Academic Journal
Live attenuated Salmonella Typhimurium with monophosphoryl lipid A retains ability to induce T-cell and humoral immune responses against heterologous polysaccharide of Shigella flexneri 2a
| Title: | Live attenuated Salmonella Typhimurium with monophosphoryl lipid A retains ability to induce T-cell and humoral immune responses against heterologous polysaccharide of Shigella flexneri 2a |
|---|---|
| Authors: | Qing Liu, Huali Su, Xiaoping Bian, Shifeng Wang, Qingke Kong |
| Source: | International Journal of Medical Microbiology, Vol 310, Iss 5, Pp 151427- (2020) |
| Publisher Information: | Elsevier, 2020. |
| Publication Year: | 2020 |
| Collection: | LCC:Microbiology LCC:Other systems of medicine |
| Subject Terms: | Recombinant attenuated Salmonella vaccine, Shigella flexneri 2a, O-antigen polysaccharide, Antigen delivery, Microbiology, QR1-502, Other systems of medicine, RZ201-999 |
| More Details: | Shigella flexneri 2a (Sf2a) is one of the most frequently isolated Shigella strains that causes the endemic shigellosis in developing countries. In this study, we used recombinant attenuated Salmonella vaccine (RASV) strains to deliver Sf2a O-antigen and characterized the immune responses induced by the vectored O-antigen. First, we identified genes sufficient for biosynthesis of Sf2a O-antigen. A plasmid containing the identified genes was then introduced into the RASV strains, which were manipulated to produce only the heterologous O-antigen and modified lipid A. After oral immunization of mice, we demonstrated that RASV strains could induce potent humoral immune responses as well as robust CD4+ T-cell responses against Sf2a Lipopolysaccharide (LPS) and protect mice against virulent Sf2a challenge. The induced serum antibodies mediated high levels of Shigella-specific serum bactericidal activity and C3 deposition. Moreover, the IgG+ B220low/int BM cell and T follicular helper (Tfh) cell responses could also be triggered effectively. The live attenuated Salmonella with the modified lipid A delivering Sf2a O-antigen polysaccharide showed the same ability to induce immune responses against Sf2a LPS as the strain with the original lipid A. These findings underscore the potential of RASV delivered Sf2a O-antigen for induction of robust CD4+ T-cell and IgG responses and warrant further studies toward the development of Shigella vaccine candidates with RASV strains. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 1438-4221 |
| Relation: | http://www.sciencedirect.com/science/article/pii/S1438422120300370; https://doaj.org/toc/1438-4221 |
| DOI: | 10.1016/j.ijmm.2020.151427 |
| Access URL: | https://doaj.org/article/bcaa8082c9bb4ee7ac98d913615e4342 |
| Accession Number: | edsdoj.bcaa8082c9bb4ee7ac98d913615e4342 |
| Database: | Directory of Open Access Journals |
| ISSN: | 14384221 |
|---|---|
| DOI: | 10.1016/j.ijmm.2020.151427 |
| Published in: | International Journal of Medical Microbiology |
| Language: | English |